文献速递冠心病

多支血管病变冠脉搭桥:多支动脉与单支动脉移植对比

Multiple Versus Single Arterial Coronary Bypass Graft Surgery for Multivessel Disease.
PubMed 文献 · J Am Coll Cardiol · 2019-01-01

基于纽约心脏注册数据库63,402例多支血管病变行冠状动脉旁路移植术患者,采用38项基线特征倾向匹配比较多支动脉移植(MAG)与单支动脉移植(SAG)结局(中位随访6.5年)。匹配前20%手术采用MAG;1年死亡率无差异,7年时MAG死亡率、复合终点及再次血运重建率均更低。

要点

  • 匹配后1年MAG与SAG死亡率无差异,7年时MAG死亡率更低。
  • 7年时MAG的死亡、心梗、卒中复合终点及再次血运重建率均更低。
  • off-pump、右冠病变的两支病变、近期心梗、肾功能不全及≥70岁患者中MAG未见死亡率获益。

核心结论

  • 多支血管病变患者中,MAG与SAG的1年死亡率和复合终点相似,但7年时MAG的死亡率和复合终点更低。
  • MAG患者7年再次血运重建率更低;高容量MAG术者的MAG死亡率更低。

研究设计与样本

  • 基于纽约心脏注册数据库的观察性研究,纳入2005年1月1日至2014年12月31日行冠状动脉旁路移植术的多支血管病变患者63,402例。
  • 采用38项基线特征进行倾向匹配以比较MAG与SAG结局,中位随访6.5年;主要终点为死亡,次要终点包括再次血运重建及死亡、急性心肌梗死和卒中的复合终点。

主要发现

  • 匹配前20%手术采用MAG。
  • 匹配后1年MAG与SAG死亡率无差异(2.4% vs. 2.2%,AHR 1.11;95%CI 0.93–1.32)。
  • 7年时MAG死亡率更低(12.7% vs. 14.3%,AHR 0.86;95%CI 0.79–0.93)。
  • 7年时MAG复合终点更低(20.2% vs. 22.8%,AHR 0.88;95%CI 0.83–0.93),再次血运重建率更低(11.7% vs. 14.6%,AHR 0.80;95%CI 0.74–0.87)。
  • 7年时MAG未见死亡率更低的亚组包括off-pump手术、右冠状动脉病变的两支病变、近期急性心肌梗死、肾功能不全及年龄≥70岁患者。

临床怎么用

  • 多支血管病变搭桥决策中,MAG的获益主要体现在中长期而非1年,需结合患者亚组特征个体化选择。
  • off-pump、右冠病变的两支病变、近期心梗、肾功能不全及高龄患者中MAG的死亡率获益不明显,应审慎评估。

局限性

  • 本研究为基于注册数据库的观察性研究,虽经38项特征倾向匹配,仍可能存在未测量混杂。
  • 原文摘要未报告随机对照设计,结论需结合随机研究证据解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite recent guideline statements, there is still wide practice variation in the use of multiple arterial grafts (MAGs) versus single arterial grafts (SAGs) for patients with multivessel disease undergoing coronary artery bypass graft surgery. This may be related to differences in findings between observational and randomized controlled studies. OBJECTIVES: This study sought to compare intermediate-term MAG and SAG outcomes with enhanced matching to reduce selection bias. METHODS: New York's cardiac registry identified 63,402 multivessel disease patients undergoing coronary artery bypass graft surgery between January 1, 2005, and December 31, 2014, to compare outcomes (median follow-up 6.5 years) for patients receiving SAGs and MAGs. SAG and MAG patients were propensity matched using 38 baseline characteristics to reduce selection bias. The primary endpoint was mortality, and secondary endpoints included repeat revascularization and a composite endpoint of mortality, acute myocardial infarction, and stroke. RESULTS: Before matching, 20% of procedures employed MAG. At 1 year, there was no mortality difference between matched MAG and SAG patients (2.4% vs. 2.2%, adjusted hazard ratio [AHR]: 1.11; 95% confidence interval [CI]: 0.93 to 1.32). At 7 years, MAG patients had lower mortality (12.7% vs. 14.3%, AHR: 0.86; 95% CI: 0.79 to 0.93), a lower composite outcome (20.2% vs. 22.8%, AHR: 0.88; 95% CI: 0.83 to 0.93), and a lower repeat revascularization rate (11.7% vs. 14.6%, AHR: 0.80; 95% CI: 0.74 to 0.87). At 7 years, the subgroups for which MAG did not have a lower mortality rate included patients with off-pump surgery, 2-vessel disease with right coronary artery disease, recent acute myocardial infarction, renal dysfunction, and patient ≥70 years of age. CONCLUSIONS: Mortality and the composite outcome were similar between MAG and SAG patients at 1 year, but lower for MAG after 7 years. Patients of higher volume MAG surgeons experienced lower MAG mortality.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Samadashvili Z, Sundt TM, Wechsler A, et al. Multiple Versus Single Arterial Coronary Bypass Graft Surgery for Multivessel Disease. J Am Coll Cardiol. 2019. PMID: 31488263. doi:10.1016/j.jacc.2019.06.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。